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Background: Sitagliptin, a dipeptidyl peptidase-4 (DPP4) inhibitor, reduces myocardial infarct size (IS) in nondiabetic mice. Ischemic and 
pharmacological preconditioning of diabetic animals is limited. DPP4 inhibition decreases degradation of GLP-1. Activation of the GLP-1 receptors 
increases intracellular cAMP with downstream activation of protein kinase A (PKA). Cilostazol (Cil) is a phosphodiesterase III inhibitor that prevents 
the degradation of cAMP. Cil augments the IS-limiting effects of statins. We assessed whether Cil augments the IS-limiting effects of MK0626 (MK), a 
DPP4 inhibitor, by increasing intracellular cAMP in mice with type-2 diabetes mellitus. 
Methods: Db/Db mice fed a Western Diet received 3-day pretreatment with MK (0, 1, 2 or 3 mg/kg/d) with or without Cil (15 mg/kg/d) by oral 
gavage. Mice were subjected to 30 min coronary artery occlusion and 24h reperfusion. Ischemic area at risk (AR) was assessed by blue dye and IS 
by TTC. cAMP levels were measured by ELISA. 
Results: Cil and MK at 2 and 3 mg/kg/d significantly reduced IS (Figure). Cil and MK had additive effects. IS was the smallest in the MK-3+Cil. MK 
dose dependently and Cil increased cAMP levels (p<0.001). cAMP levels were higher in the combination groups. 
Conclusion: MK and Cil have additive IS-limiting effects in diabetic mice. The additive effects are associated with an increase in myocardial cAMP 
levels.
 
